DaVita Inc. (DVA) News

DaVita Inc. (DVA): $130.42

0.98 (-0.75%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

B

Add DVA to Watchlist
Sign Up

Industry: Medical - Services

Industry

C

Ranked

#5 of 68

in industry

Filter DVA News Items

DVA News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

DVA News Highlights

  • DVA's 30 day story count now stands at 21.
  • Over the past 10 days, the trend for DVA's stories per day has been choppy and unclear. It has oscillated between 1 and 4.
  • TOP, LZ and MPTI are the most mentioned tickers in articles about DVA.

Latest DVA News From Around the Web

Below are the latest news stories about DAVITA INC that investors may wish to consider to help them evaluate DVA as an investment opportunity.

Brookdale (BKD) Concludes Transactions to Extend Debt Repayment

Brookdale (BKD) completes two financing transactions to push its debt maturities until September 2025, thereby relieving it from the debt repayment burden for next year and focusing on core operations.

Yahoo | December 28, 2023

3 Reasons to Hold Zimmer Biomet (ZBH) Stock in Your Portfolio

Zimmer Biomet's (ZBH) focus on emerging markets raises optimism about the stock.

Yahoo | December 28, 2023

Three Reasons to Add Ecolab (ECL) Stock to Your Portfolio

Ecolab's (ECL) focus on R&D raises optimism about the stock.

Yahoo | December 28, 2023

The Zacks Analyst Blog Highlights DaVita, GE HealthCare Technologies and Hologic

DaVita, GE HealthCare Technologies and Hologic are part of the Zacks top Analyst Blog.

Yahoo | December 28, 2023

DVA vs. CHE: Which Stock Is the Better Value Option?

DVA vs. CHE: Which Stock Is the Better Value Option?

Yahoo | December 27, 2023

3 Beaten-Down MedTech Stocks Poised for a Turnaround in 2024

Here are some dirt-cheap MedTech value stocks - DVA, GEHC, HOLX - which are expected to provide long-term gains.

Yahoo | December 27, 2023

McKesson (MCK) Announces Availability of PNH's FDA-Approved Drug

The availability of the FDA-approved drug via McKesson's (MCK) independent specialty pharmacy is expected to give patients more treatment options for PNH.

Yahoo | December 26, 2023

Three Reasons to Add DaVita (DVA) Stock to Your Portfolio

DaVita's (DVA) strength in its DaVita Kidney Care raises optimism about the stock.

Yahoo | December 26, 2023

Should Value Investors Buy DaVita (DVA) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Yahoo | December 25, 2023

Here's Why You Should Retain Veeva Systems (VEEV) Stock Now

Veeva Systems' (VEEV) strong product portfolio raises optimism about the stock.

Yahoo | December 22, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!